AWM
HURA

Apollon Wealth Management’s TuHURA Biosciences HURA Stock Holding History

Apollon Wealth Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$283K Buy
158,010
+23,717
+18% +$29.1K ﹤0.01% 1151
2025
Q4 		$102K Buy
134,293
+767
+0.6% +$1.47K ﹤0.01% 1262
2025
Q3 		$331K Buy
133,526
+18,252
+16% +$48K 0.01% 1014
2025
Q2 		$257K Buy
115,274
+348
+0.3% +$1.18K 0.01% 1073
2025
Q1 		$371K Buy
114,926
+53,154
+86% +$196K 0.01% 869
2024
Q4 		$253K Buy
+61,772
New +$328K 0.01% 1007

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Apollon Wealth Management's HURA Position: Q1 2026 in Review

Apollon Wealth Management increased its TuHURA Biosciences (HURA) stake by 18% in Q1 2026, buying an estimated $29.1K and bringing the position to 158,010 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Apollon Wealth Management first reported a position in HURA in Q4 2024 and has held it in 6 quarters since. The position peaked at $371K in Q1 2025. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Apollon Wealth Management held 158,010 shares of TuHURA Biosciences worth $283K as of Q1 2026.
  • Apollon Wealth Management bought 23,717 TuHURA Biosciences shares in Q1 2026, an estimated $29.1K.
  • TuHURA Biosciences made up ﹤0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #1151 holding.
  • Apollon Wealth Management first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Apollon Wealth Management's TuHURA Biosciences position peaked at $371K in Q1 2025.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.